Controversies in Hyperkalaemia Management and Practical Approaches
Controversy is good. But when it comes to hyperkalaemia management, we need solutions.
Chair, Prof Sydney Tang (University of Hong Kong, HK) Prof Chuan-Ming Hao (Huashan Hospital, CN) and Dr Kieran McCafferty (Queen Mary University London, UK) discuss the implementation of hyperkalaemia management strategies for patients with CKD in line with recent guidelines updates.
The objectives of this educational symposium are to:
- Highlight the burden associated with hyperkalaemia and the impact this has on the use of guideline-directed medical therapy for the treatment of CKD
- Outline the recent updates to KDIGO guidelines around the use of potassium binders to optimise RAASi
- Explain how guideline recommendations can be translated to daily clinical practice
Target Audience
- Cardiologists
- Nephrologists
More from this programme
Part 1
Controversies in Hyperkalaemia Management
Part 2
New guidelines: Advice for managing RAASi in patients with Hyperkalaemia
Part 3
Managing Hyperkalaemia in the real world today: A case-based study
Part 4
Panel discussion and Q&A
| 1 session | |
| Panel discussion and Q&A | Watch now |
Faculty Biographies
Kieran McCafferty
Consultant Nephrologist
Dr Kieran McCafferty is a Consultant Nephrologist at Barts Health NHS Trust and a Senior Lecturer at Queen Mary University of London. His clinical work is focused on the care of patients with complex kidney disease, with particular expertise in diabetic kidney disease and haemodialysis. Alongside his clinical responsibilities, Dr McCafferty has developed a strong academic and leadership profile within nephrology and clinical research, with a clear emphasis on improving patient-centred outcomes through high-quality clinical trials.
Academic History
Dr McCafferty holds an academic appointment as Senior Lecturer at Queen Mary University of London, reflecting his combined clinical and research roles. His academic interests bridge basic science and clinical medicine, with a particular focus on uraemic cardiovascular disease and mechanisms of cardiovascular protection in patients with chronic kidney disease.
While his foundational research interests lie…